What’s Driving Growth in the Anti-Neoplastic Agents Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Anticipated CAGR of the Anti-Neoplastic Agents Market, and What Factors Will Drive It?
The market for anti-neoplastic agents has experienced significant expansion in the previous years. It is projected to increase from $130.01 billion in 2024 to $142.82 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 9.9%. This exponential increase during the historical period can be attributed to factors such as a rise in cancer cases, heightened demand for therapeutic treatments, an increase in preference for minimally invasive cancer treatment, along with the need for cost-effective anti-neoplastic remedies.
The market for anti-neoplastic agents is predicted to experience robust expansion in the upcoming years, escalating to $202.12 billion in 2029 with a compound annual growth rate (CAGR) of 9.1%. The proliferation in this projected period can be linked to increased patient knowledge and awareness, governmental efforts, a rising demand for individualized cancer treatment, and a growing emphasis on quality of life during cancer care. Noteworthy trends within this forecast period encompass progress in oncology research, the creation of targeted therapies, biotechnological advancements, and improvements within diagnostic instruments.
How Are the key drivers expanding the growth of the anti-neoplastic agents Market?
The anticipated growth of the antineoplastic agent market is largely tied to the surge in cancer cases. Cancer encompasses a range of diseases that occur when abnormal cells grow out of control, breach their typical boundaries, and either invade neighboring bodily parts or spread to different organs. Antineoplastic agents are critical to cancer therapy as they curb cancer cell growth and multiplication via several methods, such as damaging DNA, disrupting the cell cycle, and interfering with essential cellular pathways. For example, the International Agency for Research on Cancer (IARC) – a French-based international body promoting global cancer research collaboration – estimates that the global cancer burden would rise to over 35 million in 2050, up by 77% from the projected 20 million in 2022 come February 2024. Hence, the mounting number of cancer cases is fueling growth in the antineoplastic agent market. Influence on the Anti-Neoplastic Agents Market: Surge in Cancer Research Investment Spurs Anti-Neoplastic Agent Market Growth
Get Your Free Sample of the Global Anti-Neoplastic Agents Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12901&type=smp
Who Are the Top Companies Contributing to the Growth of the Anti-Neoplastic Agents Market?
Major companies operating in the anti-neoplastic agents market are:
• Pfizer Inc._x000D_
• F. Hoffmann-La Roche Ltd._x000D_
• Merck & Co. Inc._x000D_
• Bayer AG_x000D_
• Novartis AG_x000D_
How Are Technological Trends Affecting the Growth and Development of the Anti-Neoplastic Agents Market?
Leading corporations within the anti-neoplastic agent market are striving to innovate in clinical practices to maintain their market position. For example, the pharmaceutical company based in Switzerland, Novartis AG, reported the approval of Pluvicto by the Food and Drug Administration (FDA) in March 2022. This is the first targeted radioligand therapy intended for the treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer (mCRPC). The recommendation is to administer 7.4 GBq (200 mCi) of Pluvicto intravenously every six weeks, with a cap of six doses, or until disease progression or intolerable toxicity, whichever occurs first. Pluvicto is to be used to treat patients with previously treated mCRPC, based on the presence of PSMA in tumors, using Locametz or other approved PSMA-11 imaging agents for selection.
Get Instant Access to the Global Anti-Neoplastic Agents Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/anti-neoplastic-agents-global-market-report
Which Primary Segments of the Anti-Neoplastic Agents Market Are Driving Growth and Industry Transformations?
The anti-neoplastic agents market covered in this report is segmented –
1) By Type: Alkylating Agents, Antimetabolites, Hormones And Antagonists, Miscellaneous
2) By Disease Type: Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Other Disease Types
3) By End User: Hospitals, Clinics, Cancer Rehabilitation Centers, Ambulatory Surgical Centers
Subsegments:
1) By Alkylating Agents: Nitrogen Mustards, Alkyl Sulfonates, Nitrosoureas, Triazines
2) By Antimetabolites: Purine Analogues, Pyrimidine Analogues, Folate Antagonists
3) By Hormones and Antagonists: Estrogens and Antiestrogens, Androgens and Antiandrogens, Glucocorticoids
4) By Miscellaneous: Vinca Alkaloids, Taxanes, Antibiotic Antineoplastics, Targeted Therapy Agents
What Are the Key Regions Powering Growth in the Anti-Neoplastic Agents Market?
North America was the largest region in the anti-neoplastic agents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anti-neoplastic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Defining Features of the Anti-Neoplastic Agents Market?
Anti-neoplastic agents refer to drugs that inhibit or destroy abnormal tissue growth, specifically targeting and combating cancerous cells in the body. They have a vital role in cancer treatment by disrupting the processes involved in tumor development and progression.
Browse Through More Similar Reports By The Business Research Company:
Esophagoscopes And Gastroscopes Global Market Report 2024
Flexible Endoscopes Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/flexible-endoscopes-global-market-report
Abdominal Aortic Aneurysm (AAA) Repair Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
